Truqap 200 MG tablet 64S
Ended Awarded
- Contract number
- SPE2DB25FNTBS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,514
Award facts
- Contract value 100% obligated
- $15,514.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded May 9, 2025, represents a $15.5K firm fixed price purchase of Truqap 200 mg tablets (64-count) from AmerisourceBergen Drug Corp, the nation's leading pharmaceutical distributor. The contract, with an ultimate completion date of June 2, 2025, is funded by the Defense Logistics Agency (DLA), which procures medical supplies and pharmaceuticals for the Department of Defense. This non-competitive award constitutes a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1B through December 2026, which serves as the primary pharmaceutical supply vehicle for military healthcare systems globally. Performance will be executed from the contractor's corporate office in Conshohocken, Pennsylvania.
AmerisourceBergen's comprehensive $1B IDC with DLA enables the company to supply an extensive portfolio of pharmaceuticals, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems. The company's federal contracting activity demonstrates consistent capability in fulfilling competitive procurement requirements and managing both routine and specialized medical supply deliveries. The DLA's upcoming Pharmaceutical Prime Vendor Global Program Generation V initiative is expected to establish multiple regional contracts among several qualified contractors, positioning AmerisourceBergen to continue serving as a critical supplier within this strategic framework for military medical readiness and operations.
Quick answers
Who was awarded contract SPE2DB25FNTBS?
SPE2DB25FNTBS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 9, 2025.
How much is contract SPE2DB25FNTBS worth?
The government has obligated $15,514 on SPE2DB25FNTBS.
Is contract SPE2DB25FNTBS an order under another contract?
Yes. SPE2DB25FNTBS is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB25FNTBS competed?
The extent of competition for SPE2DB25FNTBS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award